Signs of Opioid Addiction: A Clinical Field Guide

Medically reviewed by Dr. Richard A. Marasa, MD, MBA — Board-Certified in Addiction Medicine, Emergency Medicine & Internal Medicine

Opioid addiction is a chronic medical disease characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. The clinical term is opioid use disorder (OUD). According to the DSM-5-TR, OUD is diagnosed when a person meets 2 or more of 11 specific criteria within a 12-month period (APA, 2022). Recognizing the signs early — physical, behavioral, and psychological — is often the difference between a contained medical problem and a life-threatening one, especially as the illicit opioid supply has become overwhelmingly contaminated with fentanyl.

How opioid addiction is diagnosed: DSM-5-TR criteria

The American Psychiatric Association's DSM-5-TR defines opioid use disorder through 11 specific criteria covering tolerance, withdrawal, loss of control, time spent using, cravings, failure to meet obligations, continued use despite problems, giving up activities, hazardous use, and use despite physical or psychological harm (APA, 2022). A clinician diagnoses OUD when at least 2 criteria are present over a 12-month period. Severity is rated by count: 2–3 criteria is mild, 4–5 is moderate, and 6 or more is severe. This matters because treatment intensity is calibrated to severity — someone with mild OUD may respond to outpatient medication and counseling, while moderate-to-severe OUD typically warrants structured medication-assisted treatment (MAT) with closer monitoring.

Two of the 11 criteria — tolerance and withdrawal — are waived when a person is taking opioids exactly as prescribed by a physician. That distinction is the hinge between dependence and addiction.

The 11 DSM-5-TR criteria (summary)

• Taking opioids in larger amounts or for longer than intended
• Persistent desire or unsuccessful efforts to cut down
• Significant time spent obtaining, using, or recovering from opioids
• Craving or strong urge to use opioids
• Failing to meet major role obligations at work, school, or home
• Continued use despite social or interpersonal problems
• Giving up important activities because of opioid use
• Recurrent use in physically hazardous situations
• Continued use despite physical or psychological problems
• Tolerance (needing more for the same effect)
• Withdrawal (or using opioids to avoid it)

Dependence vs. addiction: why the distinction matters

Physical dependence on opioids is a predictable neuroadaptation — the body adjusts to the presence of the drug and produces withdrawal symptoms when it is stopped. Dependence can develop with any sustained opioid use, including medically appropriate treatment after surgery or for chronic pain (NIDA, 2023). Addiction, by contrast, is a behavioral disease defined by compulsive use despite harm. A post-surgical patient who needs a taper is dependent but not addicted. A person who keeps using despite losing their job, lying to family, and buying pills from strangers meets the behavioral criteria for OUD. Conflating the two does real harm: it leads clinicians to undertreat legitimate pain, and it leads families to overlook genuine addiction because "the prescription is legal."

The practical test Dr. Marasa uses in clinic: dependence resolves when the drug is tapered under medical supervision. Addiction does not — the drive to use persists even when the drug is no longer physiologically needed.

Physical signs of opioid addiction

Physical signs of opioid use are driven by how opioids act on the central nervous system. Opioids bind to mu-opioid receptors, which slows breathing, constricts pupils, suppresses cough, blunts pain, and reduces gut motility (NIDA, 2023). When someone is using regularly, those effects cluster in a recognizable pattern. Between doses — as the drug's effect wears off — the body rebounds into a flu-like withdrawal state within 8–24 hours for short-acting opioids like heroin or oxycodone, and within 24–48 hours for longer-acting opioids. Loved ones often describe a "two-person" pattern: someone who is sedated and slurred shortly after a dose, then anxious, sweaty, and irritable a few hours later. None of these signs alone confirms OUD, but a cluster over weeks warrants a clinical conversation.

Signs seen while someone is using opioids

• Pinpoint pupils (miosis) — pupils constricted to 2 mm or smaller, even in dim light
• Drowsiness, "nodding off" — drifting in and out of sleep mid-conversation or mid-activity
• Slurred speech and slowed responses
• Slowed, shallow breathing — the most dangerous sign; respiratory depression is how opioids kill
• Constant itching, often on the face, nose, and arms
• Nausea or vomiting, especially early in use
• Severe constipation — opioids slow gut transit dramatically

Signs seen between doses (early withdrawal)

• Yawning, runny nose, watery eyes, sneezing
• Goosebumps, chills, sweating
• Muscle aches and restless legs
• Anxiety, irritability, insomnia
• Abdominal cramps, diarrhea

Signs that develop over months

• Weight loss and poor appetite
• Dental problems from reduced saliva and neglected hygiene
• Track marks — small puncture marks, bruising, or darkened veins along the arms, legs, hands, or feet (for intravenous use)
• Skin infections, abscesses, or cellulitis at injection sites

Behavioral signs of opioid addiction

Behavioral signs are often what finally alerts a family, because they show up in the spaces between the person and their life. The Substance Abuse and Mental Health Services Administration describes the behavioral pattern of OUD as a gradual narrowing — as the disorder progresses, more of the person's time, money, and attention gets funneled toward securing and using opioids (SAMHSA, 2023). Early on, this looks like small, deniable changes: a prescription that runs out a few days early, a missed dinner, a small amount of money that "disappeared." Later, it looks unmistakable: job loss, legal trouble, stolen jewelry, canceled relationships. Behavioral signs matter diagnostically because the DSM-5-TR weights them heavily — 7 of the 11 OUD criteria are behavioral or social, not physical (APA, 2022).

Prescription-related behaviors

• "Doctor shopping" — seeing multiple prescribers for the same complaint
• Running out of prescriptions days or weeks early
• Hoarding pill bottles, counting pills, rationing compulsively
• Requesting early refills with vague justifications
• Losing prescriptions repeatedly
• Using someone else's prescription or giving one's own away

Lifestyle and social behaviors

• Withdrawal from family, friends, or previously loved activities
• Secretive phone use; unexplained trips that take "just a minute"
• New social circle that loved ones haven't met
• Financial problems — unpaid bills, borrowed money, selling possessions
• Missed work, slipping performance, or sudden job loss
• Legal issues — DUIs, possession charges, theft
• Lying about use or minimizing obvious intoxication

Psychological signs of opioid addiction

Psychological signs reflect what is happening inside the brain's reward and stress systems. Chronic opioid use down-regulates the brain's own endogenous opioid production and sensitizes the stress (norepinephrine) system, so the person feels worse at baseline and needs the drug just to feel normal (NIDA, 2023). This neurobiology drives the classic pattern: preoccupation with the next dose, intense cravings, and mood that tracks the drug's availability — calm right after using, anxious and depressed as the dose wears off. Many people with OUD also meet criteria for a co-occurring mood or anxiety disorder, and the two conditions feed each other. Psychological signs are often the earliest to appear in someone using prescription opioids, because they precede visible physical decline.

What psychological signs look like

• Preoccupation — thinking about the next dose well before it is due
• Cravings — intense urges to use, triggered by cues (locations, people, emotions)
• Mood swings — sedated or euphoric after using, irritable or depressed between doses
• Anxiety that rises sharply as the previous dose wears off
• Depression, low motivation, and anhedonia (loss of pleasure)
• Defensiveness or denial when use is raised by loved ones
• Using despite knowing it is causing harm — the core cognitive feature of addiction

The fentanyl era: why signs look different now

Today's illicit opioid supply is not what it was a decade ago. Illicitly manufactured fentanyl now dominates the street drug market, and in 2023 synthetic opioids — primarily illicit fentanyl and fentanyl analogs — were involved in roughly 69% of U.S. overdose deaths, with nearly 73,000 fatal overdoses tied to synthetic opioids that year (CDC, 2024). Fentanyl is roughly 50 times more potent than heroin, which means signs can escalate faster and overdoses happen earlier in the trajectory of use. Pressed pills sold as "oxycodone," "Percocet," or "Xanax" are frequently counterfeit and contain fentanyl in unpredictable doses; the New England Journal of Medicine and CDC have both documented the shift toward a fentanyl-contaminated supply (CDC, 2024). If a loved one uses any opioid obtained outside a pharmacy, assume fentanyl exposure is a realistic risk and keep naloxone (Narcan) accessible.

What fentanyl-era signs can add to the picture

• Very rapid onset of use disorder — weeks, not months, from first use
• More severe and more frequent withdrawal because fentanyl clears quickly
• Higher rate of non-fatal overdoses ("blue lips" episodes, unresponsive spells)
• Test strips, naloxone, or fentanyl-specific paraphernalia in the home

Naloxone is available without a prescription at most U.S. pharmacies (FDA, 2023). Anyone living with a person who uses opioids — prescribed or not — should have it on hand and know how to use it. Many states also distribute naloxone free of charge through public health departments and community harm-reduction programs; in New Hampshire, The Doorway network connects families to free naloxone and overdose-prevention training, and Massachusetts runs a similar statewide program through the Department of Public Health. Fentanyl test strips, while not a substitute for avoiding the illicit supply, can detect fentanyl in a sample and are legal in a growing number of states. None of these tools replace treatment, but they meaningfully reduce the risk that a bad day becomes a fatal one while someone is moving toward care.

Who is at higher risk for opioid use disorder?

Opioid use disorder is not a character flaw — it is a disease with measurable risk factors. NIDA identifies several variables that meaningfully raise the likelihood that opioid exposure will progress to OUD: a personal or family history of substance use disorder, untreated mental health conditions (especially depression, anxiety, PTSD, and ADHD), early-life adversity, chronic pain, and social factors like unemployment, housing instability, and isolation (NIDA, 2023). Genetic studies suggest that roughly 40–60% of vulnerability to substance use disorders is heritable. Risk also varies with exposure pattern: higher prescribed doses, longer duration of therapy, and prescriptions for opioids with faster onset of action all increase risk, as does any period of using opioids obtained outside a medical setting. None of these factors are deterministic — plenty of people with multiple risk factors never develop OUD — but recognizing them helps patients, prescribers, and families calibrate caution.

Common risk factors

• Personal history of any substance use disorder (alcohol, tobacco, other drugs)
• Family history of addiction
• Co-occurring mental health conditions — depression, anxiety, PTSD, ADHD, bipolar disorder
• History of trauma or adverse childhood experiences (ACEs)
• Chronic pain, especially when combined with limited non-opioid pain management
• Long duration or high daily dose of prescribed opioids
• Social isolation, unstable housing, or unemployment
• Exposure to an opioid-using peer group or household

How to recognize signs in a loved one without accusing them

Families often hesitate to raise concerns because they are afraid of being wrong, or of pushing their loved one away. The evidence-based approach — reflected in SAMHSA's guidance for families — is to lead with specific observations, express care, and avoid labels (SAMHSA, 2023). Instead of "you're an addict," try "I noticed the pills ran out five days early this month, and I've been worried." Instead of an ultimatum, offer a concrete next step: a call to a clinician, an appointment you've already looked up, a ride to an assessment. Choose a moment when the person is not intoxicated, not in withdrawal, and not surrounded by an audience. Tell them what you see, tell them you love them, and tell them what you need. Readiness to change moves in stages — some conversations don't land the first time, but they do shift the calculus for later.

Conversation starters that tend to work

• "I've been noticing some things that worry me. Can we talk about it?"
• "I'm not angry. I'm scared, and I want to help."
• "I looked up an outpatient program that could help. Would you come with me for an evaluation?"
• "Whatever you decide, I want you to have naloxone in the house. Can we at least do that?"

If your loved one is not ready, resources like SMART Recovery Family & Friends and Al-Anon can help you cope and stay connected without enabling. Staying in relationship — even imperfectly — is one of the strongest protective factors a person with OUD can have.

Can someone be addicted to prescribed opioids?

Yes, although it is less common than the public conversation suggests. A systematic review published in Pain estimated that among patients prescribed opioids for chronic pain, rates of diagnosable opioid use disorder range from roughly 8% to 12%, depending on the population and criteria used (Vowles et al., 2015; consistent with more recent cohort analyses). The risk is real but not universal — most patients who take opioids as prescribed for a defined period do not develop OUD. What matters is honest monitoring: a prescriber who asks about early refill requests, functional changes, and family concerns, and a patient who reports symptoms accurately. If you are a patient worried about your own use, raise it with your prescriber before the prescription runs out — you will get a more compassionate response than you expect, and treatment options are broader than most people realize.

If you recognize these signs: what to do next

Recognition is a starting point, not a verdict. Opioid use disorder is among the most treatable chronic conditions in medicine: medication-assisted treatment (MAT) — buprenorphine (often as Suboxone), methadone, and extended-release naltrexone — is the clinical gold standard and reduces overdose mortality substantially (SAMHSA, 2023; NIDA, 2024). MAT works best when combined with counseling, peer support, and care for any co-occurring mental health conditions. For a deeper look at specific medications, see Clear Steps Recovery's guides to top medications for addiction treatment, purple heroin and the fentanyl-contaminated supply, and how long heroin stays in your system.

If you are a family member: approach the conversation when your loved one is not intoxicated, lead with specific observations rather than labels ("I noticed X" rather than "you're an addict"), and have a treatment option ready to offer. If you are the person using: you do not have to be in crisis to ask for help, and you will not be judged for starting the conversation.

Clear Steps Recovery provides outpatient opioid addiction treatment including MAT, individual and group counseling, and support for co-occurring conditions, in Londonderry, NH and Needham, MA. Every article on this site is medically reviewed by Dr. Richard Marasa, our Medical Director and a physician board-certified in Addiction Medicine. Call (603) 769-8981 (NH) or (781) 765-0001 (MA) for a confidential assessment — our admissions team is available 24/7. In an overdose emergency, call 911 and administer naloxone if available. For 24/7 national support, SAMHSA's helpline is 1-800-662-HELP (4357).